| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 60.9% | 28/46 |
| Female | 39.1% | 18/46 |
| Indifferent | 0% | 0/46 |
| Unknown | 0% | 0/46 |
| General | ||
| 13% | 6/46 | |
| 8.7% | 4/46 | |
| 8.7% | 4/46 | |
| 15.2% | 7/46 | |
| 21.7% | 10/46 | |
| 21.7% | 10/46 | |
| 56.5% | 26/46 | |
| 91.3% | 42/46 | |
| 63% | 29/46 | |
| 75.9% | 22/29 | |
| Neurology | ||
| 78.3% | 36/46 | |
| 50% | 23/46 | |
| 28.3% | 13/46 | |
| Facial abnormalities | ||
| 17.4% | 8/46 | |
| 47.8% | 22/46 | |
| 19.6% | 9/46 | |
| 28.3% | 13/46 | |
| Visual and hearing impairments | ||
| 8.7% | 4/46 | |
| 43.5% | 20/46 | |
| Heart | ||
| 4.3% | 2/46 | |
| Pulmonary | ||
| 8.7% | 4/46 | |
| Gastrointestinal | ||
| 26.1% | 12/46 | |
| Urogenital | ||
| 10.9% | 5/46 | |
| Skeleton | ||
| 50% | 23/46 | |
| Skin / Hair / Nails | ||
| 26.1% | 12/46 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/46 |
| 2.2% | 1/46 | |
| 8.7% | 4/46 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/46 |
| Inheritance | ||
| 74.4% | 32/43 | |
SOX5